AI-generated · cited to primary sources · not investment advice
Quick Heal Tech (539678) May 2025 Filing Analysis
Where does growth come from?
Profitability has reversed into negative territory as the company increases spending on R&D and Sales/Marketing to fuel its enterprise transition. (2 reversing across 2 signals)
“EBITDA % Q4 FY24 12.6%... Q3 FY25 -5.3%... Q4 FY25 -13.0%”
The company's potential market size is expanding rapidly, growing from 1100 Cr in FY23 to 3000 Cr in FY25, with a target of 4000 Cr by FY27. (3 accelerating, 2 steady across 5 signals)
“Evolution of Serviceable Operatable Market... FY 23 1100 Cr... FY 24 1800 Cr... FY 25 3000 Cr”
See the full cited Future Growth analysis of Quick Heal Tech
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.